Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 14, 2018
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
Masanori Kawakami, Lisa Maria Mustachio, Lin Zheng, et al.
International Journal of Oncology
|
August 28, 2012
Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations
Fabrizio Galimberti, Alexander M Busch, Fadzai Chinyengetere, et al.
JCI Insight
|
May 19, 2026
Derivation and characterization of ubiquitin-specific protease 18 inhibitors
Blessing O Ogunlade, Kevin N Dalby, Samuel C Okpechi, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models
Konstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
Molecular Cancer Therapeutics
|
May 21, 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
Tian Ma, Fabrizio Galimberti, Cherie P Erkmen, et al.
Scientific Reports
|
September 9, 2023
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
Cheng-Hsin Wei, Lu Huang, Blair Kreh, et al.
Molecular Cancer Therapeutics
|
December 5, 2020
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
Masanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.
BMC Cancer
|
November 12, 2015
Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas
Fadzai Chinyengetere, David J Sekula, Yun Lu, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Molecular Cancer Research : MCR
|
March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
Lisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Proceedings of the National Academy of Sciences of the United States of America
|
February 14, 2018
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
Masanori Kawakami, Lisa Maria Mustachio, Lin Zheng, et al.
International Journal of Oncology
|
August 28, 2012
Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations
Fabrizio Galimberti, Alexander M Busch, Fadzai Chinyengetere, et al.
JCI Insight
|
May 19, 2026
Derivation and characterization of ubiquitin-specific protease 18 inhibitors
Blessing O Ogunlade, Kevin N Dalby, Samuel C Okpechi, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models
Konstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
Molecular Cancer Therapeutics
|
May 21, 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
Tian Ma, Fabrizio Galimberti, Cherie P Erkmen, et al.
Scientific Reports
|
September 9, 2023
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
Cheng-Hsin Wei, Lu Huang, Blair Kreh, et al.
Molecular Cancer Therapeutics
|
December 5, 2020
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
Masanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.
BMC Cancer
|
November 12, 2015
Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas
Fadzai Chinyengetere, David J Sekula, Yun Lu, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Molecular Cancer Research : MCR
|
March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
Lisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Page
of 9